Projects

MEDIZINISCHE HOCHSCHULE HANNOVER - Germany 

Project overview (since 2010-01-01):

 next >>
Start dateProjectacronymrolefundingpartners
2023-01-01Custom-Made Designer Macrophages to Revolutionize the Safety of Parenteral Drugs iPYROcoordinator150.0001
2022-12-01Rehabilitation and Diagnosis of Hearing Loss based on Electric Acoustic Interaction READIHEARcoordinator1.978.8751
2022-10-01Next-generation AAV vectors for liver-directed gene therapy AAVolutionparticipant4.000.0009
2022-09-01Pre-clinical development of a lentiviral gene therapy to treat hearing and balance loss in Usher 1B patients MY-O-SENSEScoordinator150.0001
2022-09-01HLA-homozygous iPSC-cardiomyocytE Aggregate manufacturing technoLogies for allogenic cell therapy to the heart HEALcoordinator5.824.07410
2022-08-01Targeting cardiac fibrosis with next generation RNA therapeutics FIBREXcoordinator2.499.4821
2020-11-01Accelerating Research & Development for Advanced Therapies ARDATparticipant11.773.00034
2020-10-01Spinal Muscular Atrophy (SMA) beyond motoneuron degeneration: multi-system aspects SMABEYONDparticipant2.142.7359
2020-07-01Noncoding RNA MEG3 inhibitor for Heart Failure Treatment MEGFIBcoordinator150.0001
2020-02-01Communication for Children with Hearing Impairment to optimise Language Development Comm4CHILDparticipant4.094.92010
2020-01-01From iPSC-Macrophage Biology Towards Regenerative Therapies Targeting Respiratory Infections iPSC2Therapycoordinator1.499.1001
2020-01-01THERVACB: A THERAPEUTIC VACCINE TO CURE HEPATITIS B TherVacBparticipant10.425.68618
2020-01-01Action Leveraging Evidence to Reduce perinatal morTality and morbidity in sub-Saharan Africa ALERTparticipant3.999.9768
2019-12-01Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies imSAVARparticipant10.999.31628
2019-09-01Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions 3TRparticipant40.273.19270
2019-06-01TRAIN-HEART TRAIN-HEARTparticipant3.940.38916
2019-05-01Gene therapy of inherited and acquired hearing loss iHEARcoordinator1.999.5001
2019-01-01MyPal: Fostering Palliative Care of Adults and Children with Cancer through Advanced Patient Reported Outcome Systems MyPalparticipant3.999.30916
2019-01-01CardioReGenix: Development of Next-Generation Gene Therapies for Cardiovascular Disease CardioReGenixparticipant14.839.77413
2019-01-01Medical Device Obligations Taskforce MDOTparticipant8.348.63414
2019-01-01European-Latin American network for the assessment of biomarkers to predict and diagnose hepatobiliary malignancies and characterization of risk factors for cancer development ESCALONparticipant3.283.47513
2019-01-01Reshaping undesired Inflammation in challenged Tissue Homeostasis by Next-Generation regulatory T cell (Treg) Approaches – from Advanced Technology Developments to First-in-Human Trials RESHAPEparticipant13.137.39610
2018-11-01Promoting smart specialization at the Technical University of Moldova by developing the field of Novel Nanomaterials for BioMedical Applications through excellence in research and twinning NanoMedTwinparticipant999.6936
2018-10-01Promoting patient safety by a novel combination of imaging technologies for biodegradable magnesium implants MgSafeparticipant3.956.39913
2018-06-01MAnufacturing of TUmour-REactive Natural Killer cells MATURE-NKcoordinator3.351.66214
2018-06-01Hanover experimental lung research project XHaLecoordinator1.989.2501
2018-02-01An in silico-based approach to improve the efficacy and precision of drug REPurpOsing TRIALs for a mechanism-based patient cohort with predominant cerebro-cardiovascular phenotypes REPO-TRIALparticipant5.536.77313
2018-01-01Adeno-Associated Virus Vector-Mediated Liver Gene Therapy for Crigler-Najjar Syndrome CureCNparticipant6.249.10411
2018-01-01Stem-cell based gene therapy for recombination deficient SCID (RECOMB) RECOMBparticipant5.990.46017
2017-10-01Aerodynamic and Flexible Trucks for Next Generation of Long Distance Road Transport AEROFLEXparticipant9.534.77925
2017-09-01Exploiting GLIOblastoma intractability to address European research TRAINing needs in translational brain tumour research, cancer systems medicine and integrative multi-omics GLIOTRAINparticipant3.836.77223
2017-06-01Targeting the transcriptional landscape in infant AML iAML-lncTARGETparticipant1.499.7501
2017-01-01Towards enduring mouse resources and services advancing research into human health and disease INFRAFRONTIER2020participant4.955.87730
2017-01-01HARMONIzation and integrative analysis of regional, national and international Cohorts on primary Sjögren’s Syndrome (pSS) towards improved stratification, treatment and health policy making HarmonicSSparticipant9.998.75039
2016-05-01Training network providing cutting-EDGE knowlEDGE on Herpes Virology and Immunology EDGEparticipant3.961.9439
2016-03-01Synergy-based Open-source Foundations and Technologies for Prosthetics and RehabilitatiOn SoftProparticipant7.440.02614
2016-01-01Tools and TECHNOlogies for Breakthrough in hEArt Therapies TECHNOBEATcoordinator5.968.8508
2016-01-01DevelopIng Genetic medicines for Severe Combined Immunodeficiency (SCID) SCIDNETparticipant6.926.31312
2015-12-01microRNA biomarkers in an innovative biophotonic sensor kit for high-specific diagnosis miRNA-DisEASYparticipant445.5007
2015-10-01novel bioreactor Platform for reprOducible, Scalable ExpansIonand cardiac DifferentiatiON of hiPSC in suspension culture POSEIDONcoordinator159.4611
2015-08-01iABC Programme IABC PROGRAMMEparticipant24.331.60922
2015-07-01Personalized Nanomedicines for Leukemia Patients PNANOMEDparticipant1.499.7501
2015-06-01Development and disease of the renal tract RENALTRACTparticipant3.137.3778
2015-06-01Exploring selected long non-coding RNAs as diagnostics and therapeutic targets for heart failure LONGHEARTcoordinator1.816.2501
2015-05-01Safety CaUsation, Benefits and Efficiency SafetyCubeparticipant5.790.11117
2015-01-01Aortic Valve Replacement using Individualised Regenerative Allografts: Bridging the Therapeutic Gap ARISEcoordinator4.954.9929
2014-04-01Immune and Neuromodulation Mediated by Alphaherpesviruses INMAcoordinator100.0001
2014-01-01Individualized Implant Placement IIPparticipant150.0002
2013-12-01Parasite glycobiology and anti-parasitic strategies GLYCOPARparticipant3.450.85612
2013-11-01Targets and biomarkers for antiepileptogenesis EPITARGETparticipant11.999.97518
 next >>